MedTrace Logo

Subtenon and Intravenous Dexmedetomidine Effect on Patients Undergoing Cataract Surgery

NCT04668456 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2021-02-25

No results posted yet for this study

Summary

The study designed to compare the effects and the safety of adding dexmedetomidine to local anesthetics and its intravenous administration in subtenon block in patients undergoing cataract surgery.

Conditions

  • Acute Postoperative Pain

Interventions

DRUG

Dexmedetomidine

the drug administered either subtenon ot iv

DRUG

lidocaine 2%

subtenon injection

DRUG

bupivacine 0.5%

subtenon injection

DRUG

Normal saline

either subtenon or iv

Sponsors & Collaborators

  • Menoufia University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-08-15
Primary Completion
2021-03-14
Completion
2021-03-30
FDA Drug
Yes

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04668456 on ClinicalTrials.gov